Schedules of controlled substances: temporary placement of three synthetic cathinones in  Schedule I. Final Order.
The Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule three synthetic cathinones under the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 4-methyl-N-methylcathinone (mephedrone), 3,4-methylenedioxy-N-methylcathinone (methylone), and 3,4-methylenedioxypyrovalerone (MDPV). This action is based on a finding by the Administrator that the placement of these synthetic cathinones and their salts, isomers, and salts of isomers into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the full effect of the CSA and its implementing regulations including criminal, civil and administrative penalties, sanctions and regulatory controls of Schedule I substances will be imposed on the manufacture, distribution, possession, importation, and exportation of these synthetic cathinones.
D000470:Alkaloids / Q000009:adverse effects / Q000145:classification*; D052117:Benzodioxoles / Q000009:adverse effects / Q000145:classification*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000145:classification*; D015198:Designer Drugs / Q000009:adverse effects / Q000145:classification*; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D004349:Drug Packaging / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000145:classification*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000145:classification*; D011759:Pyrrolidines / Q000009:adverse effects / Q000145:classification*; D019966:Substance-Related Disorders; D014481:United States
D000470:Alkaloids; D052117:Benzodioxoles; D000697:Central Nervous System Stimulants; D015198:Designer Drugs; D011619:Psychotropic Drugs; D011759:Pyrrolidines; D008694:Methamphetamine; C023665:cathinone